Access cutting-edge major depressive disorder treatment through this clinical trial at a research site in Clermont. Study-provided care at no cost to qualified participants.
Access major depressive disorder specialists in Clermont at no cost
This study follows strict safety protocols and ethical guidelines
All study-related major depressive disorder treatment provided free
The goal of this clinical trial is to determine the pharmacodynamic effects of ALTO-203 in patients with MDD in a randomized, placebo-controlled, single-dose crossover treatment period. Additionally, safety, tolerability, and PK will be assessed in a subsequent randomized placebo-controlled multi-dose parallel-group treatment period of 28 days. Participants will complete subjective response questionnaires and perform cognitive tasks during the single-dose period, in which participants will rece
Sponsor: Alto Neuroscience
Check if you qualify for this major depressive disorder clinical trial in Clermont, FL
If you're searching for major depressive disorder treatment options in Clermont, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Clermont research site is actively enrolling participants for this clinical trial. You'll receive care from experienced major depressive disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.